Granules India Expands Internationally

Granules India (Hyderabad, India), an active pharmaceutical ingredient (API) and pharmaceutical formulation intermediate (PFI) producer, says it is expanding its international presence through two recent deals. The company and Hubei Biocause Pharmaceutical Company Ltd. (Wuhan, China) recently received approval from the Chinese government to set up a 50-50 joint venture company in China, most likely at the city of Hubei. Separately, contract manufacturer Matchland (Eagle Farm, Australia) has agreed to outsource manufacturing of its finished-dosage formulations for...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers